Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

10 Results

Guidelines and Advice

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2015

Status: Current
ID: PET 2015-2

May 2016

Guidelines and Advice

Positron Emission Tomography in Hodgkin Lymphoma Patients Undergoing Curative-Intent Treatment

Status: Current
ID: 27-4

Mar 2016

Guidelines and Advice

Preoperative or Postoperative Therapy for Resectable Esophageal Cancer

Status: In-Review
ID: 2-11
Version: 4

Jun 2016

Guidelines and Advice

Primary Treatment for Locally Advanced Cervical Cancer: Concurrent Platinum-Based Chemotherapy and Radiation

Status: In-Review
ID: 4-5

Jun 2016

Guidelines and Advice

Provider Tools for Advance Care Planning and Goals of Care Discussions

Status: Archived
ID: 18-2

Sep 2016

Guidelines and Advice

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2016

Status: Current
ID: pet 2016-1

Nov 2016

Cancer facts

Percentage of Women Late for Cervical Screening Varies Geographically

Dec 2016

Statistical Reports

Prevention System Quality Index 2016

Sep 2016

Drug

pegfilgrastim

Other Name(s): Neulasta®, Lapelga®, Fulphila™; Ziextenzo®; Nyvepria™, Niopeg®, Pexegra™

Quick Link(s):

Drug Monograph, Patient Info Sheet

Updated

Aug 2025

Drug

pegylated liposomal DOXOrubicin

Other Name(s): Caelyx®

Quick Link(s):

Drug Monograph, Patient Info Sheet

Updated

Aug 2025